## Abstract ## Background Intravenous bisphosphonate therapy has been used for treatment of benign and malignant bone diseases and has been linked to osteonecrosis of the jaws. ## Methods Records of 638 patients treated with intravenous bisphosphonates were reviewed. Drug used, number of infusio
Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis
✍ Scribed by Christian Walter; Knut A. Grötz; Martin Kunkel; Bilal Al-Nawas
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 115 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background. An increasing number of cases of osteonecrosis of the jaws (ONJ) in patients treated with bisphosphonates has been reported in the literature. ONJ significantly affects the patients' quality of life and its management is still extremely difficult. ## Methods. A woman w
## Abstract ## Background. Osteonecrosis of the jaws occurs after the administration of bisphosphonates. An unequivocal treatment strategy is yet to be devised. We assess the treatment of patients with bisphosphonate‐related osteonecrosis of the jaws (BRONJ). ## Methods. The investigators studie
We read with great interest the article by Wutzl et al, 1 reporting a well-designed prospective study for the treatment of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in a cohort of multiple myeloma, breast cancer, and other diseases in patients. The authors duly report patients' under